OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
About | OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
OpenEvidence and NEJM Group, publisher of the New England Journal of . . . CAMBRIDGE, MA, February 19, 2025 – OpenEvidence, the fastest-growing platform for doctors, has signed a multi-year content agreement with NEJM Group, publisher of the New England Journal of Medicine (NEJM) Under this agreement, all published content and multimedia from 1990 forward from NEJM, NEJM Evidence, NEJM AI, NEJM Catalyst, and NEJM Journal Watch will be provided to OpenEvidence to
Announcements - OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
OpenEvidence 2. 0 Now Available We are excited to announce OpenEvidence 2 0 In addition to medical search, OpenEvidence now fully supports administrative and clinical workflow use cases, including:
OpenEvidence AI becomes the first AI in history to score above 90% on . . . OpenEvidence AI, the large language model-based artificial intelligence powering the automatic ingestion, analysis, synthesis, and research on openevidence com, has reached a new milestone as the first AI to score over 90% on the United States Medical Licensing Examination (USMLE) OpenEvidence makes 77% fewer errors on the US Medical Licensing Exam than ChatGPT, 24% fewer errors than GPT-4
OpenEvidence to Become a Mayo Clinic Platform Accelerate Company OpenEvidence, an AI company pursuing foundational work in aligning Large Language Models (LLMs) to the medical domain, announced today it is to become a Mayo Clinic Platform Accelerate company As part of Mayo Clinic Platform Accelerate, OpenEvidence will collaborate with Mayo Clinic Platform to improve how health care information is structured and discovered
National Organization for Rare Disorders and OpenEvidence Partner to . . . NORWELL, Mass , and MIAMI, Fla (March 12, 2026) - The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families
OpenEvidence | Trust Center OpenEvidence is committed to carefully protecting and securing your data and ensuring that OpenEvidence com is always available when you need it We use a variety of industry-standard technologies and services to safeguard your data from unauthorized access, disclosure, use, and loss, and are constantly monitoring and improving our products and services We fully comply with the U S Health